HomeINBX • NASDAQ
add
Inhibrx Biosciences Inc
Previous close
$66.46
Day range
$65.32 - $68.00
Year range
$10.81 - $94.57
Market cap
976.55M USD
Avg Volume
196.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.57M | -66.54% |
Net income | -32.83M | 31.40% |
Net profit margin | — | — |
Earnings per share | -2.11 | 52.80% |
EBITDA | -30.36M | 38.34% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 124.22M | -18.60% |
Total assets | 146.48M | -18.97% |
Total liabilities | 138.48M | 193.51% |
Total equity | 7.99M | — |
Shares outstanding | 14.61M | — |
Price to book | 120.84 | — |
Return on assets | -47.73% | — |
Return on capital | -59.76% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -32.83M | 31.40% |
Cash from operations | -30.12M | 31.10% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 1.25M | — |
Net change in cash | -28.87M | 33.99% |
Free cash flow | -19.91M | 27.24% |
About
Founded
2024
Headquarters
Website
Employees
110
